Cargando…

Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter

Multidrug resistance in lung cancer cells is a significant obstacle in the treatment of lung cancer. Resistance to chemotherapeutic agents is often the result of efflux of the drugs from cancer cells, mediated by adenosine triphosphate (ATP)-dependent drug transport across the plasma membrane. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldfinger, Lawrence E, Lee, Seunghyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240306/ https://www.ncbi.nlm.nih.gov/pubmed/25419163 http://dx.doi.org/10.2147/LCTT.S53672

Ejemplares similares

A potential function of RLIP76 in the ovarian corpus luteum
por: Billhaq, Dody Houston, et al.
Publicado: (2019)

RLIP76: A Structural and Functional Triumvirate
por: Cornish, Jasmine, et al.
Publicado: (2021)

Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?
por: Hindle, Ashly, et al.
Publicado: (2022)

RLIP76, a non-ABC transporter, and drug resistance in epilepsy
por: Awasthi, Sanjay, et al.
Publicado: (2005)

RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration
por: Goldfinger, Lawrence E., et al.
Publicado: (2006)

A Central Role of RLIP76 in Regulation of Glycemic Control
por: Awasthi, Sanjay, et al.
Publicado: (2010)

Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence
por: Fan, Song-Yuan, et al.
Publicado: (2015)

2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer
por: Nagaprashantha, Lokesh Dalasanur, et al.
Publicado: (2018)

Headliners: Cancer: Inhibition of RLIP76 Causes Complete Regression of Melanoma in Mice
por: Phelps, Jerry
Publicado: (2006)

Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer
por: Nagaprashantha, Lokesh Dalasanur, et al.
Publicado: (2022)

RLIP76, a Glutathione-Conjugate Transporter, Plays a Major Role in the Pathogenesis of Metabolic Syndrome
por: Singhal, Jyotsana, et al.
Publicado: (2011)

RLIP76 Gene Variants are not Associated with Drug Response in Turkish Epilepsy Patients
por: Manguoğlu, E, et al.
Publicado: (2011)

RLIP76 decreases apoptosis through Akt/mTOR signaling pathway in gastric cancer
por: Wang, Wenwen, et al.
Publicado: (2018)

RLIP76 decreases apoptosis through Akt/mTOR signaling pathway in gastric cancer
por: Wang, Wenwen, et al.
Publicado: (2016)

Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases
por: Hurd, Catherine A., et al.
Publicado: (2020)

RLIP76 Regulates PI3K/Akt Signaling and Chemo-Radiotherapy Resistance in Pancreatic Cancer
por: Leake, Kathryn, et al.
Publicado: (2012)

Increased RLIP76 expression in IDH1 wild-type glioblastoma multiforme is associated with worse prognosis
por: Wang, Qi, et al.
Publicado: (2020)

Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells
por: Bennani-Baiti, Barbara, et al.
Publicado: (2015)

Rlip Depletion Suppresses Growth of Breast Cancer
por: Bose, Chhanda, et al.
Publicado: (2020)

Rlip Protein: A Potential Target for COVID-19
por: Kopel, Jonathan, et al.
Publicado: (2022)

The Structure of the RLIP76 RhoGAP-Ral Binding Domain Dyad: Fixed Position of the Domains Leads to Dual Engagement of Small G Proteins at the Membrane
por: Rajasekar, Karthik V., et al.
Publicado: (2013)

Rlip Depletion Alters Oncogene Transcription at Multiple Distinct Regulatory Levels
por: Hindle, Ashly, et al.
Publicado: (2022)

Rlip depletion prevents spontaneous neoplasia in TP53 null mice
por: Awasthi, Sanjay, et al.
Publicado: (2018)

Identification and Characterization of the RLIP/RALBP1 Interacting Protein Xreps1 in Xenopus laevis Early Development
por: Boissel, Laurent, et al.
Publicado: (2012)

Platelet Microparticles and miRNA Transfer in Cancer Progression: Many Targets, Modes of Action, and Effects Across Cancer Stages
por: Lazar, Sophia, et al.
Publicado: (2018)

Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights
por: Reddy, P. Hemachandra, et al.
Publicado: (2023)

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2021)

Amino acid transporters as emerging therapeutic targets in cancer
por: Saito, Yasuhiro, et al.
Publicado: (2021)

The Ubiquitin System: An Emerging Therapeutic Target for Lung Cancer
por: Jin, Jun-O, et al.
Publicado: (2021)

Emerging immunotherapy targets in lung cancer
por: Zhu, Hao-Hua, et al.
Publicado: (2020)

The Role of the Guanosine Nucleotide-Binding Protein in the Corpus Luteum
por: Billhaq, Dody Houston, et al.
Publicado: (2021)

Targeting uptake transporters for cancer imaging and treatment
por: Zhang, Yuchen, et al.
Publicado: (2020)

SIGMA 76
por: Reinfelds, J, et al.
Publicado: (1977)

The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
por: Häfliger, Pascal, et al.
Publicado: (2019)

Ovarian cancer: emerging molecular-targeted therapies
por: Sourbier, Carole
Publicado: (2012)

Molecular Targets and Emerging Therapies for Advanced Gallbladder Cancer
por: Canale, Matteo, et al.
Publicado: (2021)

The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
por: Yuan, Min, et al.
Publicado: (2019)

Emerging transporter-targeted nanoparticulate drug delivery systems
por: Su, Hongyan, et al.
Publicado: (2019)

ADAM17: An Emerging Therapeutic Target for Lung Cancer
por: Saad, Mohamed I., et al.
Publicado: (2019)

Molecular pathways and therapeutic targets in lung cancer
por: Shtivelman, Emma, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lb21k45fd7bpbef7acl989u26h